Investigation of T-cell fitness and mechanisms of drug resistance in selinexor treated patients with relapsed/refractory multiple myeloma
Publication
, Conference
Kang, Y; Neff, J; Gasparetto, C; Wang, X; Ellero, A; Walker, C
Published in: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2023
Duke Scholars
Published In
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
EISSN
2152-2669
ISSN
2152-2650
Publication Date
2023
Volume
23
Start / End Page
S259 / S259
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kang, Y., Neff, J., Gasparetto, C., Wang, X., Ellero, A., & Walker, C. (2023). Investigation of T-cell fitness and mechanisms of drug resistance in selinexor treated patients with relapsed/refractory multiple myeloma. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (Vol. 23, pp. S259–S259).
Kang, Yubin, Jadee Neff, Cristina Gasparetto, Xiaobei Wang, Andrea Ellero, and Christopher Walker. “Investigation of T-cell fitness and mechanisms of drug resistance in selinexor treated patients with relapsed/refractory multiple myeloma.” In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 23:S259–S259, 2023.
Kang Y, Neff J, Gasparetto C, Wang X, Ellero A, Walker C. Investigation of T-cell fitness and mechanisms of drug resistance in selinexor treated patients with relapsed/refractory multiple myeloma. In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2023. p. S259–S259.
Kang, Yubin, et al. “Investigation of T-cell fitness and mechanisms of drug resistance in selinexor treated patients with relapsed/refractory multiple myeloma.” CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 23, 2023, pp. S259–S259.
Kang Y, Neff J, Gasparetto C, Wang X, Ellero A, Walker C. Investigation of T-cell fitness and mechanisms of drug resistance in selinexor treated patients with relapsed/refractory multiple myeloma. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2023. p. S259–S259.
Published In
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
EISSN
2152-2669
ISSN
2152-2650
Publication Date
2023
Volume
23
Start / End Page
S259 / S259
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences